Zhejiang Medicine Stock Hits Day Low of CNY 16.47 Amid Price Pressure

Zhejiang Medicine Co., Ltd. experienced a notable decline today, with the stock dropping by 5.05% as it reached an intraday low of CNY 16.47. This performance contrasts sharply with the China Shanghai Composite, which recorded a modest gain of 0.65% on the same day. Over the past week, Zhejiang Medicine's stock has shown a slight decrease of 0.12%, while its monthly performance remains positive at 3.78%. However, the company has underperformed relative to the broader market over the past year, achieving a return of only 7.02% compared to the China Shanghai Composite's impressive 22.49%. Despite the recent downturn, Zhejiang Medicine has reported positive results for the last four consecutive quarters, with operating cash flow reaching a high of CNY 2,018.84 million. The company maintains a strong cash position, with cash and equivalents totaling CNY 6,124.58 million. Its return on equity stands at 12.47%, indicating a solid valuation with a price-to-book ratio of 1.22. However, the company's long-term growth has been modest, with net sales growing at an annual rate of 4.64% over the past five years.